The developer of
Russia’s pioneering Covid-19 vaccine says monitoring of recipients has shown no
side effects that had not been identified during earlier clinical trials.
Russia is to boost vaccination pace starting next week.
So far some 1.5
million people received doses of the Sputnik V vaccine, and now Russia is
preparing to upscale the immunization campaign. Commenting on the development
on Thursday, the head of the research lab that developed the vaccine reassured
the public about its safety.
According to Gintsburg, the production of Sputnik V for Russia’s needs has reached 3.5 million doses per month, with plans to further boost the capacity. Two doses administered weeks apart are necessary to properly immunize a person.
No comments:
Post a Comment